Cited by 95Asthma and respiratory diseasesAntibiotic Use and ResistanceChronic Obstructive Pulmonary Disease (COPD) Research

Assessing the association of early life antibiotic prescription with asthma exacerbations, impaired antiviral immunity, and genetic variants in 17q21: A population-based birth cohort study

Open access
Semic-Jusufagic, Aida, Belgrave, Danielle, Pickles, Andrew, Telcian, Aurica G, Bakhsoliani, Eteri, Sykes, Annemarie, Simpson, Angela, Johnston, Sebastian L +1 more·2014·The Lancet Respiratory Medicine

Abstract

BACKGROUND: The relationship between early-life antibiotic use and the development of wheeze and asthma has been reported in several studies but might arise as a consequence of bias rather than causal relationship. We investigated the association between antibiotic prescription and subsequent development of atopy, wheeze, and asthma exacerbations, and the relation of early life antibiotic prescription with anti-infective immunity and genetic variants on asthma susceptibility locus 17q21. METHODS: Children in a population-based birth cohort were followed from birth to age 11 years. Information on antibiotic prescription, wheeze, and asthma exacerbations was extracted from medical records, and the effect of antibiotic prescription assessed with longitudinal analyses. We assessed immune responses of peripheral blood mononuclear cells, taken at age 11 years, to viruses (rhinovirus and respiratory syncytial virus; RSV) and bacteria (Haemophilus influenzae and Streptococcus pneumoniae) in children who either received at least one or no antibiotic prescriptions in infancy. Finally, we assessed the association of 17q21 polymorphisms with antibiotic prescription. FINDINGS: Of 984 families who gave consent, we extracted data for 916 children. We noted significantly higher risk of physician-confirmed wheezing after antibiotic prescription (hazard ratio [HR] 1·71, 95% CI 1·32-2·23; p<0·0001) and severe wheeze or asthma exacerbation after antibiotic prescription (HR 2·26, 95% CI 1·03-4·94; p=0·041). In children who wheezed, the hazards of exacerbations (2·09, 1·51-2·90; p<0·0001) and admissions to hospital (2·64, 1·49-4·70; p=0·0009) were significantly increased in the 2 years after the first antibiotic prescription. Children who received antibiotics in infancy had significantly lower induction of cytokines, which are important in host defence against virus infections to both RSV and rhinovirus; there were no differences in antibacterial responses. Variants in 17q21 were associated with an increased risk of early life antibiotic prescription. INTERPRETATION: The association between antibiotics and asthma might arise through a complex confounding by indication. Hidden factors that may increase the likelihood of both early life antibiotic prescription and later asthma are an increased susceptibility to viral infections consequent upon impaired antiviral immunity and genetic variants on 17q21. FUNDING: Moulton Charitable Foundation and Medical Research Council.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-2600(14)70096-7

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Early life antibiotic exposure in humans appears to impair antiviral immunity, but this relationship may not be causal and may be explained by genetic variants impacting antiviral immunity.

    “Early life antibiotic exposure in humans also appears to impair antiviral immunity, however this relationship may not be causal but rather explained by genetic variants impacting antiviral immunity (Semic-Jusufagic et al., 2014).”

    From Viral Infections, the Microbiome, and Probiotics (2021) · cites this paper as Semic-Jusufagic et al., 2014

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Edwards MR, Bartlett NW, Hussell T, Openshaw P, Johnston SL. The microbiology of as thma. Nat Rev Microbiol 2012; 10: 459-71.

Cited by

Sorted by citations

Authors
Semic-Jusufagic, A., Belgrave, D., Pickles, A., Telcian, A. G., Bakhsoliani, E., Sykes, A., Simpson, A., Johnston, S. L., & Custovic, A.
Affiliations
  • University of Manchester (GB)
  • King's College London (GB)
  • Asthma UK (GB)
Venue
The Lancet Respiratory Medicine
Publisher
Elsevier BV
Published
2014-08
Volume
2
Issue
8
Pages
621-630
ISSN
2213-2600 (ISSN-L)
OpenAlex
W1964394970
Cited by
95
References
30
Citations by year
2026: 1 · 2025: 5 · 2024: 3 · 2023: 4 · 2022: 10 · 2021: 6 · 2020: 3 · 2019: 16 · 2018: 10 · 2017: 11 · 2016: 13 · 2015: 4 · 2014: 9
FWCI
8.13
Type
journal article
Language
en
Open access
Locations
  • The Lancet Respiratory Medicine (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
  • MRC (G0601361 and MR/K002449/1)
  • JP Moulton Charitable Foundation (233015)
  • MRC Centre (G1000758)
  • Predicta FP7 Collaborative Project (260895)
Topics
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Antibiotic Use and Resistance
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords
childhood asthma, asthma exacerbations, wheezing, atopy, antiviral immunity, cytokine induction, respiratory syncytial virus, rhinovirus, Haemophilus influenzae, Streptococcus pneumoniae, confounding by indication, antibiotic overuse
MeSH terms
Age Factors, Anti-Bacterial Agents, Asthma, Cells, Cultured, Child, Child, Preschool, Chromosomes, Human, Pair 17, Egg Proteins, Follow-Up Studies, Genotype, Haemophilus influenzae, Humans, Infant, Infant, Newborn, Leukocytes, Mononuclear, Membrane Proteins, Drug Prescriptions, Prospective Studies, Surveys and Questionnaires, Respiratory Sounds, Rhinovirus, Risk Factors, Severity of Illness Index, Skin Tests, Streptococcus pneumoniae, Disease Progression, Polymorphism, Single Nucleotide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review